Autoimmune Disease Diagnosis Market

1. Autoimmune Disease Diagnosis Market Projected to Reach USD 8.3 Billion by 2030| Fatpos Global Fatpos Global has released its comprehensive market analysis report titled “Autoimmune Disease Diagnosis Market- Analysis of Market Size, Share & Trends for 2021 – 2030” The global autoimmune disease diagnosis market is expected to experience significant growth, with projections indicating an increase from USD 4.1 billion in 2020 to USD 8.3 billion by 2030. This expansion represents a compound annual growth rate (CAGR) of 8.9% over the forecast period from 2021 to 2030. The rise in autoimmune diseases, growing awareness, and advancements in research are driving this market's rapid development. Request for Sample PDF: https://www.fatposglobal.com/sample-request/autoimmune-disease- diagnosis-market-419 Market Overview Autoimmune diseases occur when the immune system mistakenly attacks the body, failing to distinguish between foreign invaders and healthy cells. This can lead to a variety of conditions, some of which target specific organs, like Type 1 diabetes, which affects the pancreas, while others, such as systemic lupus erythematosus (SLE), can impact multiple organs throughout the body. Key Market Highlights  Market Growth: The autoimmune disease diagnosis market is poised to grow at a CAGR of 8.9%, reaching USD 8.3 billion by 2030. Driving Factors: The market's growth is driven by the increasing prevalence of autoimmune diseases, heightened awareness, and advancements in research and healthcare technologies.  Recent Developments in Autoimmune Disease Diagnosis  PerkinElmer’s FDA Approval: In 2019, PerkinElmer, Inc. received FDA approval for its EUROIMMUN Anti-Tissue Transglutaminase ELISA, a tool designed to assist physicians in diagnosing or ruling out celiac disease. Exagen and GSK Collaboration: Exagen Inc. extended its partnership with GSK in 2019 to raise awareness about the challenges of diagnosing and managing lupus. ZEUS IFA Test Systems Launch: In 2019, Cambridge Life Sciences Limited introduced the ZEUS IFA Test Systems in the US, further expanding the range of diagnostic tools available.   Market Segmentation By Product Type  Consumables & Assay Kits: This segment dominated the market in 2019 and is expected to continue growing at the fastest rate. The rise in autoimmune diseases and the increasing number of product launches and approvals are key drivers of this segment's growth. By Test Type https://www.fatposglobal.com/reports/autoimmune-disease-diagnosis-market-419

2.  Routine Laboratory Tests: This segment is projected to record the highest CAGR during the forecast period, primarily due to the growing prevalence of autoimmune diseases and the availability of advanced healthcare infrastructure. Market Dynamics Drivers 1.Growing Awareness and Prevalence of Autoimmune Diseases: Increasing awareness among patients and the rising prevalence of autoimmune diseases are major factors driving market growth. Additionally, advancements in laboratory automation have enabled the simultaneous diagnosis of multiple tests, leading to quicker and more accurate results. 2.Advancements in Healthcare Technology and Infrastructure: The development of novel biomarkers, portable diagnostic equipment, and growing demand for laboratory automation are anticipated to fuel market growth. As healthcare infrastructure continues to evolve and healthcare spending increases, the sector is expected to experience significant growth. Restraints 1.Limited Access in Remote Areas: In underdeveloped countries and remote regions, lack of awareness and knowledge about autoimmune diseases hinders market growth. Additionally, inadequate funding, high treatment costs, and limited availability of treatments in these regions are significant challenges. Inquiry Before Buying:https://www.fatposglobal.com/reports/autoimmune-disease-diagnosis- market-419 Regional Analysis The autoimmune disease diagnosis market is segmented across five major regions: Europe: Europe was the largest regional market in 2019, driven by the high prevalence of chronic diseases and a growing geriatric population. The region's advanced R&D activities and the economic burden of autoimmune disorders are expected to continue fueling growth. The UK, in particular, is anticipated to maintain its dominance in the European market. North America: North America followed Europe in 2019 and is a major player in the global market due to its well-established healthcare infrastructure and significant investment in research. Asia Pacific: The Asia Pacific region is expected to experience the fastest growth during the forecast period. Factors contributing to this growth include developing healthcare infrastructure, increasing patient awareness, and high unmet medical needs. Japan is expected to lead the market in this region, with a healthy CAGR. About Us: An acronym for “Failures Are The Pillar of Success”, FATPOS Global has grown to become an end-to-end market intelligence firm. At FATPOS Global, we have emerged to become a https://www.fatposglobal.com/reports/autoimmune-disease-diagnosis-market-419

3. reliable market research and management consulting company that caters to non-profits, corporations, and government agencies. Our aim is to help organizations make the right decisions backed by reliable data, in order to help them meet their growth goals. Industry research reports offered by the company are designed to offer quantifiable information integrated with key industry insights. FATPOS aims at extending necessary data with the main aim of ensuring sustainable organizational development. Innovation and value creation have always been at the forefront of our strategies. Our analysts are ace statisticians and well-versed in developing variable matrices and work with industry experts to extend accurate and rational solutions. Contact Us: Address: 74/1, Bindal Chowk, Paltan Bazaar, Dehradun, Uttarakhand 248001, India Contact No: +91 (135) 3501691 Email: info@fatposglobal.com Web: https://www.fatposglobal.com/ https://www.fatposglobal.com/reports/autoimmune-disease-diagnosis-market-419